Marrone Bio Innovations, Inc. (NASDAQ: MBII) (“Marrone Bio”), an international leader in providing growers with sustainable bioprotection and plant health solutions to support global agricultural needs, today released a letter to shareholders from Chief Executive Officer, Kevin Helash. Dear Shareholders: As we close the third quarter, I wanted to take the opportunity to provide you with an update on our business and the steps we are taking to
October 19, 2020
· 5 min read